NCT02428946View on ClinicalTrials.gov

Bromocriptine and Insulin Sensitivity

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Insulin Sensitivity
Interventions
DRUG

Bromocriptine

Investigating the randomized order for timing of bromocriptine administration

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02428946 - Bromocriptine and Insulin Sensitivity | Biotech Hunter | Biotech Hunter